Brief: Sprint Bioscience Announces Identity Of Target Protein In Project VADA

Sprint Bioscience AB

13/05/2020 06:06

May 13 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * ANNOUNCES THE IDENTITY OF THE TARGET PROTEIN IN THE
WHOLLY-OWNED
PROJECT VADA
    * GOAL IS TO DEVELOP DRUG SUBSTANCES THAT INHIBIT PROTEIN
VACCINIA-RELATED KINASE 1 (VRK1) IN ORDER TO ENHANCE EFFECTS OF
IMMUNO-ONCOLOGY THERAPY, RADIATION THERAPY AND CHEMOTHERAPY

Source text for Eikon:  ID:nWkr5rtlz2 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))